Loading…

Protocol - Quality of Life in Cancer Survivors - Active Treatment

Add to My Toolkit
Description

Self-reported 30-item Likert style questions assessing quality of life and health, during the past week, in cancer patients during active treatment.

Specific Instructions

None

Protocol

The European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire – Core 30 (QLQ-C30) © was developed to assess the quality of life in cancer patients. It is a copyrighted instrument, which has been translated and validated in over 110 languages and has been used in more than 3,000 studies worldwide. Presently QLQ-C30 Version 3.0 © is the most recent version and should be used for all new studies.

The instrument is freely available if your study is purely for academic use. For each study, researchers are required to have an Academic User Agreement in order to use EORTC protocols. 

Studies with commercial sponsorship are required to have a Commercial User Agreement in order to use this protocol, and a fee is requested dependent on the number of patients in the study.

In order obtain the QLQ-C30 and associated modules, obtain the permission via the download process on the EORTC website https://qol.eortc.org/questionnaires/.

Availability

Limited Availability

Personnel and Training Required

None

Equipment Needs

None

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training No
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual No
Mode of Administration

Self-administered questionnaire

Lifestage

Adult, Senior

Participants

Ages 18 and older

Selection Rationale

This questionnaire was developed to assess the quality of life of cancer patients. It has been translated and validated into over 110 languages and was used in more than 3,000 studies worldwide.

Language

English

Standards
StandardNameIDSource
caDSR Common Data Elements (CDE) Cancer Outcome Quality of Life Questionnaire – Core 30 (QLQ-C30) Assessment Text 7533688 CDE Browser
Derived Variables

None

Process and Review

Not Applicable

Protocol Name from Source

Quality of Life in Cancer Patients European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire - Core 30 (QLQ-C30)

Source

European Organisation for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire – Core 30 (QLQ-C30)

General References

Nolte S1, Liegl G2, Petersen MA3, Aaronson NK4, Costantini A5, Fayers PM6, Groenvold M7, Holzner B8, Johnson CD9, Kemmler G8, Tomaszewski KA10, Waldmann A11, Young TE12, Rose M13; EORTC Quality of Life Group. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States. Eur J Cancer. 2019 Jan;107:153-163.

Quinten C, Coens C, Ghislain I, Zikos E, Sprangers M, Ringash J, Martinelli F, Ediebah D, Maringwa J, Reeve B, Greimel E, King M, Bjordal K, Flechtner H, Schmucker-Von Koch J, Taphoorn M, Weis J, Wildiers H, Velikova G, Bottomley A. The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients. Eur J Cancer 2015; 51 (18):2808-2819.

Scott NW, Etta JA, Aaronson NK, Bottomley A, Fayers PM, Groenvold M, Koller M, Kulis D, Marais D, Petersen MA, Sprangers M. An evaluation of the response category translations of the EORTC QLQ-C30 questionnaire. Qual Life Res 2013; 22:1483-1490.

Zeng L, Chow E, Zhang L, Tseng LM, Hou M-F, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chu Chie W, Bedar G, Bottomley A. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases. 2012.

Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Koch JS, Shi Q, Taphoorn MJ, Weis J, Bottomley A. Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data. Expert Rev Pharmacoecon Outcomes Res 2011.

Maringwa J, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Reeve BB, Gotay C, Greimel E, Flechtner H, Cleeland CS, Schmucker-Von Koch J, Weis J, Van Den Bent MJ, Stupp R, Taphoorn MJ, Bottomley A. Minimal clinically meaningful differences for the EORTCQLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann Oncol 2011.

Protocol ID

320901

Variables
Export Variables
Variable Name Variable IDVariable DescriptiondbGaP Mapping
Cancer Outcomes and Survivorship
Measure Name

Quality of Life in Cancer Survivors

Release Date

December 17, 2020

Definition

Questionnaire assessing health-related quality of life in cancer survivors.

Purpose

Concerns about health-related quality of life are important to cancer survivors and their families, as well as caregivers and care providers.

Keywords

European Organisation for the Research and Treatment of Cancer (EORTC): Cancer Outcomes and Survivorship

Measure Protocols
Protocol ID Protocol Name
320901 Quality of Life in Cancer Survivors - Active Treatment
320902 Quality of Life in Cancer Survivors - Long-term
Publications

There are no publications listed for this protocol.